Daily Penny Stock Gainers: MIKP, BLTI, MBYL
Sellers have redoubled their efforts, sending stocks back toward their morning lows. As has been the case with recent sell-offs, very few names have been able to go unscathed.
Such widespread weakness among stocks has helped drive Treasuries higher. As such, the yield on the benchmark 10-year Note is down to 2.16%. Amid yesterday’s whipsaw action, the Note’s yield hit a record low of about 2.03%.
MIKP – Trade Alert
Up 20% in morning trading to $.0024 with 17M shares traded
Mike the Pike Productions is based in Fort Wayne, IN and Los Angeles, CA . They develop and produce feature films, graphic novels, literary assets and concert/events. Overall, their projects are ‘Mainstream Independent’, combining a well-structured vision with top-tier talent; challenging current standards while maintaining mass appeal. Mike the Pike Productions, Inc. (Pink Sheets:MIKP.pk – News) announced that it has signed a Letter of Intent with a team of Executive Producers (EPs) to Package and Finance Mike The Pike Productions’ ‘The Skin Trade’ by George R.R. Martin, the author/creator behind HBO’s smash success, ‘Game of Thrones’.
To Read Full Story go to: http://www.pennytrader.com/quotes/MIKP.php
********************
BLTI – News Alert
Up 19.06% in morning trading to $3.3099 with 550K shares traded
BIOLASE Technology, Inc., the World’s leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products that are focused on technologies that advance the practice of dentistry and medicine. The Company’s laser products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE’s principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. Other products under development address ophthalmology and other medical and consumer markets. BIOLASE Technology, Inc. (NASDAQ: BLTI – News) today reported unaudited operating results for its second quarter and six months ended June 30, 2011. • $12.1 Million in Q2 Revenue, up 105 Percent Year over Year • Q2 GAAP Loss of $753,000, or $0.03 Loss per Share • Q2 Non-GAAP Profit of $6,000, or $0.00 per Share, Third Consecutive Quarter of Non-GAAP Profit, First Time Since the Second Quarter of 2004 • Revenue Guidance of $14.0 Million – $15.0 Million for Q3, up from $6.2 Million, Year over Year.
To Read Full Story go to: http://www.pennytrader.com/quotes/BLTI.php
********************
MBYL – News Alert
Up 10.38% in morning trading to $.0585 with 1M shares traded
Mobile is a solutions provider for telecommunications and computer convergence technology. MDC previously developed the “MDCTracker™”, and the “MDC-KidTracker™” child safety application for BlackBerry® Smartphones. MDC is committed to acquiring and developing software applications to provide real solutions that address real issues. Developing products for use in social media forums is a natural progression of the MDC’s overall business and corporate strategy. Mobile Data Corp. (”MDC”) announced the completion of due diligence in connection with a recent Letter Agreement entered into with BEET Company Ltd. (”BEET”) to acquire certain assets from BEET for the development of an application for use in various social media initiatives.
To Read Full Story go to: http://www.pennytrader.com/quotes/MBYL.php
********************
To Follow PennyTrader on Twitter: http://twitter.com/pennytrader
To Join Our Facebook Page: http://www.facebook.com/PennyTrader2
PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
Leave a Comment